BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jaiswal SR, Chakrabarti S. Natural killer cell-based immunotherapy with CTLA4Ig-primed donor lymphocytes following haploidentical transplantation. Immunotherapy 2019;11:1221-30. [DOI: 10.2217/imt-2019-0037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Jaiswal SR, Arunachalam J, Bhardwaj A, Saifullah A, Lakhchaura R, Soni M, Bhagawati G, Chakrabarti S. Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID-19 lung disease. Clin Transl Immunology 2022;11:e1359. [PMID: 35035954 DOI: 10.1002/cti2.1359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Jaiswal SR, Arunachalam J, Saifullah A, Lakhchaura R, Tailor D, Mehta A, Bhagawati G, Aiyer H, Khamar B, Malhotra SV, Chakrabarti S. Impact Of an Immune Modulator Mycobacterium-w On Adaptive Natural Killer Cells and Protection Against COVID-19.. [DOI: 10.1101/2021.12.14.21267696] [Reference Citation Analysis]
3 Jaiswal SR, Arunachalam J, Bhardwaj A, Saifullah A, Lakhchaura R, Soni M, Bhagawati G, Chakrabarti S. Impact Of Adaptive Natural Killer Cells, KLRC2 Genotype and Cytomegalovirus Reactivation On Late Mortality In Patients With Severe Covid-19 Lung Disease.. [DOI: 10.1101/2021.10.11.21264805] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bruno B, Lia G, Bonifazi F, Giaccone L. Decades of Progress in Allogeneic Stem Cell Transplantation for Multiple Myeloma. Hemato 2021;2:89-102. [DOI: 10.3390/hemato2010005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Chakrabarti S, Jaiswal SR. Haploidentical Transplantation: Challenges and Solutions. Contemporary Bone Marrow Transplantation 2021. [DOI: 10.1007/978-3-030-36358-1_19] [Reference Citation Analysis]
6 Jaiswal SR, Bhakuni P, Aiyer HM, Soni M, Bansal S, Chakrabarti S. CTLA4Ig in an Extended Schedule along with Sirolimus Improves Outcome with a Distinct Pattern of Immune Reconstitution Following Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation for Hemoglobinopathies. Biol Blood Marrow Transplant 2020;26:1469-76. [PMID: 32428732 DOI: 10.1016/j.bbmt.2020.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
7 Jaiswal SR, Bhagwati G, Aiyer HM, Sharma N, Chakrabarti S. Limiting the Impact of Methicillin-Resistant Staphylococcus Aureus in Patients Undergoing Haploidentical Transplantation. Mediterr J Hematol Infect Dis 2020;12:e2020024. [PMID: 32395213 DOI: 10.4084/MJHID.2020.024] [Reference Citation Analysis]
8 Chakrabarti S, Jaiswal SR. Haploidentical Transplantation: Challenges and Solutions. Contemporary Bone Marrow Transplantation 2020. [DOI: 10.1007/978-3-319-64938-2_19-1] [Reference Citation Analysis]